Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

[Accuracy of lactase gene C/T-13910 polymorphism and hydrogen breath test in a gastroenterology outpatient clinic: a retrospective study].

Buzás G, Fodor F, Csókay B.

Orv Hetil. 2016 Jun 19;157(25):1007-12. doi: 10.1556/650.2016.30462. Hungarian.

PMID:
27287841
2.

Molecular and clinical analysis of patients with classic and Duarte galactosemia in western Hungary.

Milánkovics I, Schuler A, Kámory E, Csókay B, Fodor F, Somogyi C, Németh K, Fekete G.

Wien Klin Wochenschr. 2010 Feb;122(3-4):95-102. doi: 10.1007/s00508-010-1311-7.

PMID:
20213376
3.

Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia.

Semsei AF, Erdélyi DJ, Ungvári I, Kámory E, Csókay B, Andrikovics H, Tordai A, Cságoly E, Falus A, Kovács GT, Szalai C.

Leuk Res. 2008 Aug;32(8):1214-20. doi: 10.1016/j.leukres.2007.12.009. Epub 2008 Feb 19.

PMID:
18243305
4.

Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.

Erdilyi DJ, Kámory E, Csókay B, Andrikovics H, Tordai A, Kiss C, Filni-Semsei A, Janszky I, Zalka A, Fekete G, Falus A, Kovács GT, Szalai C.

Pharmacogenomics J. 2008 Oct;8(5):321-7.

PMID:
17938643
5.

Rapid detection of sex chromosomal aneuploidies by QF-PCR: application in 200 men with severe oligozoospermia or azoospermia.

Fodor F, Kamory E, Csokay B, Kopa Z, Kiss A, Lantos I, Tisza T.

Genet Test. 2007 Summer;11(2):139-45.

PMID:
17627384
6.

The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia.

Erdélyi DJ, Kámory E, Zalka A, Semsei AF, Csókay B, Andrikovics H, Tordai A, Borgulya G, Magyarosy E, Galántai I, Fekete G, Falus A, Szalai C, Kovács GT.

Cell Immunol. 2006 Dec;244(2):121-4. Epub 2007 Apr 16.

PMID:
17434155
7.

Mutations causing biotinidase deficiency in children ascertained by newborn screening in Western Hungary.

Milánkovics I, Kámory E, Csókay B, Fodor F, Somogyi C, Schuler A.

Mol Genet Metab. 2007 Mar;90(3):345-8. Epub 2006 Dec 20.

PMID:
17185019
8.

Rapid detection of cystic fibrosis transmembrane conductance regulator gene IVS8 5T variant by real-time PCR.

Kámory E, Csókay B, Holló Z.

Clin Chem. 2004 Oct;50(10):1837-9. No abstract available.

10.

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E.

Int J Cancer. 2000 Jun 1;86(5):737-40.

11.

Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online.

Csokay B, Tihomirova L, Stengrevics A, Sinicka O, Olah E.

Hum Mutat. 1999;14(1):92.

PMID:
10447273
12.

High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.

Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, Olah E.

Cancer Res. 1999 Mar 1;59(5):995-8.

13.

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Ponder BA, Weber B, Devilee P, Borg A, Narod SA, Goldgar D.

Am J Hum Genet. 1998 Jun;62(6):1381-8.

14.

Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gayther SA, Csokay B, Ponder BA, Olah E.

Am J Hum Genet. 1997 May;60(5):1242-6. No abstract available.

15.

Regulation of the signal transduction program by drugs.

Weber G, Shen F, Prajda N, Yang H, Li W, Yeh A, Csokay B, Olah E, Look KY.

Adv Enzyme Regul. 1997;37:35-55.

PMID:
9381980
16.

Molecular mechanisms in the antiproliferative action of quercetin.

Csokay B, Prajda N, Weber G, Olah E.

Life Sci. 1997;60(24):2157-63.

PMID:
9188758
17.

Multidrug resistance of testis cancers: the study of clinical relevance of P-glycoprotein expression.

Eid H, Bodrogi I, Csókay B, Oláh E, Bak M.

Anticancer Res. 1996 Nov-Dec;16(6B):3447-52.

PMID:
9042205
18.

Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.

Papp J, Csokay B, Bosze P, Zalay Z, Toth J, Ponder B, Olah E.

Br J Cancer. 1996 Nov;74(10):1592-7.

19.

Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.

Olah E, Csokay B, Prajda N, Kote-Jarai Z, Yeh YA, Weber G.

Anticancer Res. 1996 Sep-Oct;16(5A):2469-77.

PMID:
8917337
20.

[Multidrug resistance of testicular cancers. (Detection of P-glycoprotein and MDR1 gene expression and their clinical connection)].

Bak M, Hanna E, Csókay B, Bodrogi I, Oláh E.

Orv Hetil. 1995 Jan 1;136(1):19-25. Hungarian.

PMID:
7845662
21.

Oncogene patterns in breast and ovarian carcinomas.

Csókay B, Papp J, Besznyák I, Bösze P, Sárosi Z, Tóth J, Zalay Z, Oláh E.

Eur J Surg Oncol. 1993 Dec;19(6):593-9.

PMID:
7903645

Supplemental Content

Loading ...
Support Center